{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:06:43Z","timestamp":1790770003664,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">MYC<\/jats:italic> rearrangement in mantle cell lymphoma (MCL) is rare, and its clinicopathologic significance is not well defined. We report 17 cases of MCL with 8q24\/<jats:italic toggle=\"yes\">MYC<\/jats:italic> rearrangement, detected at the time of initial diagnosis of MCL in 10 patients and subsequently during the clinical course in 7 patients. There were 12 men and 5 women with a median age of 61 years (range, 49 to 81 y). Fourteen patients had lymphadenopathy (Ann Arbor stage III\/IV), and 3 patients presented with a leukemic pattern without lymphadenopathy. Thirteen of 14 patients with available karyotyping data had a complex karyotype. In 8 cases the partner chromosome locus was an <jats:italic toggle=\"yes\">IG<\/jats:italic> locus: t(8;14) (n=7) and t(8;22) (n=1). When <jats:italic toggle=\"yes\">MYC<\/jats:italic> rearrangement was detected, most patients had a high-risk MCL international prognostic index, and the lymphoma cells had histologically aggressive features. Immunophenotypic analysis showed that the lymphoma cells were positive for cyclin D1 (n=16\/16), Myc (9\/11), and P53 (n=9\/9). The Ki-67 proliferation rate was high (\u226560%) in 10\/11 cases. All patients received chemotherapy. The median follow-up time was 23 months. Clinical follow-up was available for 14 patients and treatment response in 13 patients. Eleven of 13 patients had refractory or relapsed disease, and 11 patients died. In conclusion, MCL with <jats:italic toggle=\"yes\">MYC<\/jats:italic> rearrangement is characterized by advanced-stage disease, aggressive morphologic features, a high proliferation rate, p53 expression, a complex karyotype, and a poor prognosis. We believe these neoplasms fit within the overall concept of double-hit lymphoma, and the designation double-hit MCL may be helpful. We also believe that <jats:italic toggle=\"yes\">MYC<\/jats:italic> rearrangement in MCL conveys important prognostic information that should be incorporated into the pathology report.<\/jats:p>","DOI":"10.1097\/pas.0000000000000758","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T11:55:41Z","timestamp":1477137341000},"page":"216-224","source":"Crossref","is-referenced-by-count":54,"title":["Mantle Cell Lymphoma With MYC Rearrangement"],"prefix":"10.1097","volume":"41","author":[{"given":"Zhihong","family":"Hu","sequence":"first","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Chen","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[{"name":"Pathology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergej N.","family":"Konoplev","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Lu","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan V.","family":"Pham","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[{"name":"Hematopathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24094","article-title":"Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management","volume":"90","author":"Vose","year":"2015","journal-title":"Am J Hematol"},{"key":"R4-20230922","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","article-title":"Advances in the understanding of MYC-induced lymphomagenesis","volume":"149","author":"Klapproth","year":"2010","journal-title":"Br J Haematol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/his.12884","article-title":"MYC\/BCL6 double hit lymphoma (DHL): a tumor associated with an aggressive clinical course and poor prognosis","volume":"68","author":"Li","year":"2016","journal-title":"Histopathology"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PAP.0b013e3182a289f2","article-title":"MYC\/BCL2 double-hit high-grade B-cell lymphoma","volume":"20","author":"Li","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"42362","DOI":"10.18632\/oncotarget.5705","article-title":"High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival","volume":"6","author":"Yi","year":"2015","journal-title":"Oncotarget"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features","volume":"15","author":"Hao","year":"2002","journal-title":"Mod Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/10428190701852024","article-title":"Blastic mantle cell lymphoma with a Burkitt translocation","volume":"49","author":"Reddy","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"R14-20230922","first-page":"155","article-title":"Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature","volume":"6","author":"Setoodeh","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2141.2001.03056.x","article-title":"Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy","volume":"115","author":"Vaishampayan","year":"2001","journal-title":"Br J Haematol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification","volume":"122","author":"Ott","year":"2013","journal-title":"Blood"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/PAS.0000000000000434","article-title":"Triple-hit B-cell lymphoma with MYC, BCL2, and BCL6 translocations\/rearrangements: clinicopathologic features of 11 cases","volume":"39","author":"Wang","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/modpathol.2015.42","article-title":"CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases","volume":"28","author":"Li","year":"2015","journal-title":"Mod Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/S0046-8177(03)00412-X","article-title":"Cytogenetic findings in blastoid mantle cell lymphoma","volume":"34","author":"Khoury","year":"2003","journal-title":"Hum Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1996.14.4.1269","article-title":"Mantle-cell lymphoma: a population-based clinical study","volume":"14","author":"Velders","year":"1996","journal-title":"J Clin Oncol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"R25-20230922","first-page":"1591","article-title":"Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1\/CCND1) mRNA levels and proliferative activity","volume":"148","author":"Jares","year":"1996","journal-title":"Am J Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V90.8.3154","article-title":"Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity","volume":"90","author":"Ott","year":"1997","journal-title":"Blood"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/cncr.29781","article-title":"Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma","volume":"122","author":"Landsburg","year":"2016","journal-title":"Cancer"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/gcc.20831","article-title":"Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms","volume":"50","author":"Bacher","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/leu.2012.72","article-title":"Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease","volume":"26","author":"Royo","year":"2012","journal-title":"Leukemia"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201702000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:17:15Z","timestamp":1695421035000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201702000-00009"}},"subtitle":["A Report of 17 Patients"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000758","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}